Farletuzumab Ecteribulin

Farletuzumab Ecteribulin
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82929-1 1 mg - - -

3 - 8 business days*

2,761.00€
BPS-82929-2 5 mg - - -

3 - 8 business days*

7,461.00€
BPS-82929-3 10 mg - - -

3 - 8 business days*

11,134.00€
 
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the... more
Product information "Farletuzumab Ecteribulin"
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.1,2
Keywords: Anti-FBP, Anti-FOLR, Anti-FOLR1, Anti-FR-alpha, Anti-KB cells FBP, Anti-Folate receptor 1, Anti-Folate receptor alpha, Anti-Folate receptor, adult, Anti-Adult folate-binding protein, Anti-Ovarian tumor-associated antigen MOv18,
Supplier: BPS Bioscience
Supplier-Nr: 82929

Properties

Application: Cancer therapy target studies
Conjugate: No
Species reactivity: human
MW: ~149 kD
Format: Solution

Database Information

CAS : 2407465-18-1| Matching products
KEGG ID : K13649 | Matching products
UniProt ID : P15328 | Matching products
Gene ID : GeneID 2348 | Matching products

Handling & Safety

Storage: -80°C (protect from light)
Shipping: -80°C (International: -80°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Farletuzumab Ecteribulin"
Write a review
or to review a product.
Viewed